coronary artery bypass grafting), Ischemic heart disease/Chronic coronary syndrome (Myocardial infarction, percutaneous coronary intervention
Conditions
Brief summary
The following components are included in the primary endpoint, ranked in hierarchical order: 1. Cardiovascular death 2. Fatal bleeding (BARC type 5) 3. Intracranial bleeding (BARC type 3c) 4. Ischemic stroke 5. MI 6. Other major bleeding (BARC type 3a [moderate, requires transfusion] and 3b [major, may need surgery])
Detailed description
The secondary endpoints of the trial are listed below: - Each component of the primary composite outcome - All-cause mortality - Hospitalization for cardiovascular causes - Peptic ulcer - Patient-reported outcomes o Minor bleeding o Abdominal pain/discomfort o Quality of life o Health-related quality of life, anxiety and depressive symptoms, and functional status o Angina symptoms o Lifestyle behaviour
Interventions
Sponsors
Odense University Hospital
Eligibility
Sex/Gender
All
Age
65 Years to No maximum
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The following components are included in the primary endpoint, ranked in hierarchical order: 1. Cardiovascular death 2. Fatal bleeding (BARC type 5) 3. Intracranial bleeding (BARC type 3c) 4. Ischemic stroke 5. MI 6. Other major bleeding (BARC type 3a [moderate, requires transfusion] and 3b [major, may need surgery]) | — |
Secondary
| Measure | Time frame |
|---|---|
| The secondary endpoints of the trial are listed below: - Each component of the primary composite outcome - All-cause mortality - Hospitalization for cardiovascular causes - Peptic ulcer - Patient-reported outcomes o Minor bleeding o Abdominal pain/discomfort o Quality of life o Health-related quality of life, anxiety and depressive symptoms, and functional status o Angina symptoms o Lifestyle behaviour | — |
Outcome results
None listed